The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
To Dope or Not to Dope: Neuroenhancement with Prescription Drugs and Drugs of Abuse among Swiss University Students
Open accessAbstract
BACKGROUND: Neuroenhancement is the use of substances by healthy subjects to enhance mood or cognitive function. The prevalence of neuroenhancement among Swiss university students is unknown. Investigating the prevalence of neuroenhancement among students is important to monitor problematic use and evaluate the necessity of prevention programs. STUDY AIM: To describe the prevalence of the use of prescription medications and drugs of abuse for neuroenhancement among Swiss university students. METHOD: In this cross-sectional study, students at the University of Zurich, University of Basel, and Swiss Federal Institute of Technology Zurich were invited via e-mail to participate in an online survey. RESULTS: A total of 28,118 students were contacted, and 6,275 students completed the survey. Across all of the institutions, 13.8% of the respondents indicated that they had used prescription drugs (7.6%) or drugs of abuse including alcohol (7.8%) at least once specifically for neuroenhancement. The most frequently used prescription drugs for neuroenhancement were methylphenidate (4.1%), sedatives (2.7%), and beta-blockers (1.2%). Alcohol was used for this purpose by 5.6% of the participants, followed by cannabis (2.5%), amphetamines (0.4%), and cocaine (0.2%). Arguments for neuroenhancement included increased learning (66.2%), relaxation or sleep improvement (51.2%), reduced nervousness (39.1%), coping with performance pressure (34.9%), increased performance (32.2%), and experimentation (20%). Neuroenhancement was significantly more prevalent among more senior students, students who reported higher levels of stress, and students who had previously used illicit drugs. Although "soft enhancers", including coffee, energy drinks, vitamins, and tonics, were used daily in the month prior to an exam, prescription drugs or drugs of abuse were used much less frequently. CONCLUSIONS: A significant proportion of Swiss university students across most academic disciplines reported neuroenhancement with prescription drugs and drugs of abuse. However, these substances are rarely used on a daily basis and more sporadically used prior to exams.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
WILENS, T. E., ADLER, L. A., ADAMS, J., SGAMBATI, S., ROTROSEN, J., SAWTELLE, R., UTZINGER, L., & FUSILLO, S. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815a56f1 · Cited by 824
Effects of methylphenidate on spatial working memory and planning in healthy young adults
Elliott, R., Sahakian, B. J., Matthews, K., Bannerjea, A., Rimmer, J., & Robbins, T. W. (1997) · Psychopharmacology · doi:10.1007/s002130050284 · Cited by 389
Research works printed but not linked: 36
- E Hildt, 2011, Pharmacological neuroenhancement: information and acceptance among students, Nervenheilkunde, 30, 833, 10.1055/s-0038-1628433 · doi:10.1055/s-0038-1628433
- AG Franke, 2011, Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany, Pharmacopsychiatry, 44, 60, 10.1055/s-0030-1268417 · DOI · Paper page
- M Kordt, 2009, DAK Gesundheitsreport 2009, Hamburg
- C Normann, 2008, Neuroenhancement: status quo and perspectives, Eur Arch Psychiatry Clin Neurosci, 258 Suppl 5, 110, 10.1007/s00406-008-5022-2 · DOI
- Eckhardt A, Bachmann A, Marti M, Rütsche B, Telser H (2011) Human enhancement. Zürich: vdf Hochschulverlag. doi:10.3218/3404-2. · DOI
- H Greely, 2008, Towards responsible use of cognitive-enhancing drugs by the healthy, Nature, 456, 702, 10.1038/456702a · DOI · Paper page
- B Maher, 2008, Poll results: look who's doping, Nature, 452, 674, 10.1038/452674a · DOI · Paper page
- AM Arria, 2008, Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use, Pharmacotherapy, 28, 156, 10.1592/phco.28.2.156 · DOI · Paper page
- Repantis D (2009) Die Wirkung von Psychopharmaka bei Gesunden. In: Wienke A, Eberbach W, Kramer HJ, Janke K, editors. Die Verbesserung des Menschen. Tatsächliche und rechtliche Aspekte der wunscherfüllenden Medizin. Berlin Heidelberg: Springer. pp. 63–68. · doi:10.1007/978-3-642-00883-2_5
- BB Quednow, 2010, Ethics of neuroenhancement: a phantom debate, BioSocieties, 5, 153, 10.1057/biosoc.2009.13 · DOI
- H Förstl, 2009, [Neuro-enhancement. Brain doping], Der Nervenarzt, 80, 840
- SE McCabe, 2005, Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey, Addiction, 100, 96, 10.1111/j.1360-0443.2005.00944.x · DOI · Paper page
- B Sahakian, 2007, Professor's little helper, Nature, 450, 1157, 10.1038/4501157a · DOI · Paper page
- KB Kaloyanides, 2007, Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants, Pharmacotherapy, 27, 666, 10.1592/phco.27.5.666 · DOI · Paper page
- AD DeSantis, 2008, Illicit use of prescription ADHD medications on a college campus: a multimethodological approach, J American Coll Health, 57, 315, 10.3200/JACH.57.3.315-324 · DOI · Paper page
- S Sussman, 2006, Misuse of “study drugs”: prevalence, consequences, and implications for policy, Subst Abuse Treat Prev Policy, 1, 15, 10.1186/1747-597X-1-15 · DOI
- S Mache, 2012, Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences, Wiener Medizinische Wochenschrift, 162, 262, 10.1007/s10354-012-0115-y · DOI
- G Franke a, 2010, [Pharmacological neuroenhancement and brain doping: chances and risks], Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 53, 853
- P Eickenhorst, 2012, Neuroenhancement among German university students: motives, expectations, and relationship with psychoactive lifestyle drugs, J Psychoactive Drugs, 44, 418, 10.1080/02791072.2012.736845 · DOI
- P Dietz, 2013, Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students, Pharmacotherapy, 33, 44, 10.1002/phar.1166 · DOI · Paper page
- R Ott, 2012, Neuroenhancement: perspectives of Swiss psychiatrists and general practitioners, Swiss Med Weekly, 142, w13707
- D Repantis, 2010, Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review, Pharmacol Res, 62, 187, 10.1016/j.phrs.2010.04.002 · DOI · Paper page
- DC Turner, 2003, Cognitive enhancing effects of modafinil in healthy volunteers, Psychopharmacology, 165, 260, 10.1007/s00213-002-1250-8 · DOI · Paper page
- MA Wulf, 2011, Das Ringen um Sinn und Anerkennung - Eine psychodynamische Sicht auf das Phänomen des Neuroenhancement (NE), Ethik in der Medizin, 24, 29, 10.1007/s00481-011-0137-9 · DOI
- B Partridge, 2012, Australian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: perceived patterns of use, efficacy and safety, Drug Alcohol Rev, 32, 295, 10.1111/dar.12005 · DOI
- OC Banjo, 2010, Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount, PLoS One, 5, e14322, 10.1371/journal.pone.0014322 · DOI
- AG Franke, 2012, What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement, PLoS One, 7, e40047, 10.1371/journal.pone.0040047 · DOI
- V Cakic, 2009, Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology, J Med Ethics, 35, 611, 10.1136/jme.2009.030882 · DOI · Paper page
- R Kühne, 2011, Der Bezug von Methylphenidat in der Schweiz: Nicht alarmierend - Fragen stellen sich dennoch, Schweizerische Ärztezeitung, 92, 1295, 10.4414/saez.2011.16235 · DOI
- M Bruggisser, 2011, Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets, Swiss Med Weekly, 141, w13267
- SP Novak, 2007, The nonmedical use of prescription ADHD medications: results from a national Internet panel, Subst Abuse Treat Prev Policy, 2, 32, 10.1186/1747-597X-2-32 · DOI
- I Ilieva, 2013, Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people, Neuropharmacology, 64, 496, 10.1016/j.neuropharm.2012.07.021 · DOI · Paper page
- BB Quednow, 2010, Neurophysiologie des Neuro-Enhancements: Möglichkeiten Möglichkeiten und Grenzen, SuchtMagazin, 36, 19
- AG Franke, 2012, [Characteristics of university students using stimulants for cognitive enhancement: a pilot study], Psychiatr Praxis, 39, 174
- M Bruggisser, 2012, Methylphenidate misuse, Praxis, 101, 299
- S Bell, 2013, Australian university students' attitudes towards the acceptability and regulation of pharmaceuticals to improve academic performance, Neuroethics, 6, 197, 10.1007/s12152-012-9153-9 · DOI
Cited by
Dolder, P. C., Müller, F., Schmid, Y., Borgwardt, S. J., & Liechti, M. E. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4650-5 · Cited by 117
Self-citationPredictors of Illicit Drug Use Among University Students in Northern Ireland, Wales and England
El Ansari, W., Vallentin-Holbech, L., & Stock, C. (2014) · Global Journal of Health Science · doi:10.5539/gjhs.v7n4p18 · Cited by 68
“…higher levels of performance pressure with regard to education, work, leisure, or family were also more experienced with neuroenhancing drugs (Maier et al., 2013), and students may cope by abusing performance enhancing drugs or other drugs, to deal with the academic stress (Mathew & Varga,…”
InfluentialNeurocognitive, Autonomic, and Mood Effects of Adderall: A Pilot Study of Healthy College Students
Weyandt, L. L., White, T. L., Gudmundsdottir, B. G., Nitenson, A. Z., Rathkey, E. S., De Leon, K. A., & Bjorn, S. A. (2018) · Pharmacy · doi:10.3390/pharmacy6030058 · Cited by 43
Grant, J. E., Redden, S. A., Lust, K., & Chamberlain, S. R. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000448 · Cited by 39
Dolder, P. C., Strajhar, P., Vizeli, P., Odermatt, A., & Liechti, M. E. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4849-0 · Cited by 34
Self-citation
Metadata
- Authors
- Maier, L. J., Liechti, M. E., Herzig, F., & Schaub, M. P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-11-13
- Volume
- 8
- Issue
- 11
- Pages
- e77967
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2168569741
- Cited by
- 198
- References
- 2
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: To Dope or Not to Dope: Neuroenhancement with Prescription Drugs and Drugs of Abuse among Swiss University Students. https://app.cochat.ai/papers/10.1371/journal.pone.0077967
- The paper
- Maier, L. J., Liechti, M. E., Herzig, F., & Schaub, M. P. (2013). To Dope or Not to Dope: Neuroenhancement with Prescription Drugs and Drugs of Abuse among Swiss University Students. PLoS ONE. https://doi.org/10.1371/journal.pone.0077967
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.